Who owns Synta Pharmaceuticals?

Key details on Synta Pharmaceuticals (Ticker: SNTA)

Who owns Synta Pharmaceuticals?

Is SNTA a good stock to own? Find out who bought Synta Pharmaceuticals, who sold Synta Pharmaceuticals (SNTA) stock, and who holds a large position in Synta Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
CAXTON 21.76M $7.62M Dec. 31, 2015
Jennison Associates 6.62M $11.52M Sept. 30, 2015
Vanguard 4.29M $1.50M Dec. 31, 2015
FMR 3.73M $6.48M Sept. 30, 2015
Jefferies 3.24M $6.29M March 31, 2015
Renaissance Technologies 2.50M $876470 Dec. 31, 2015
BlackRock Fund Advisors 2.45M $856076 Dec. 31, 2015
Perceptive Advisors 2.38M $15.03M Sept. 30, 2013
S.A.C. Capital Advisors 2.01M $12.66M Sept. 30, 2013
ARMISTICE CAPITAL 2.00M $3.48M Sept. 30, 2015
JPMORGAN CHASE & CO 1.76M $9.22M Dec. 31, 2013
QVT Financial 1.75M $11.04M Sept. 30, 2013
Sectoral Asset Management 1.48M $11.30M Sept. 30, 2012
Baker Bros. Advisors 1.40M $6.98M June 30, 2013
GOLDMAN SACHS 1.30M $456666 Dec. 31, 2015
Barclays 1.28M $6.38M June 30, 2013
BlackRock Institutional Trust Company, N.A. 1.22M $428211 Dec. 31, 2015
CITADEL ADVISORS 1.22M $414808 Dec. 31, 2015
SUSQUEHANNA INTERNATIONAL 1.14M $3.43M Sept. 30, 2014
NORTHERN TRUST 1.06M $361703 Dec. 31, 2015
Frigate Ventures 989204 $346221 Dec. 31, 2015
STATE STREET CORPORATION 941667 $329583 Dec. 31, 2015
Ayer Capital Management 851635 $3.70M March 31, 2012
D. E. Shaw & Co 804262 $281491 Dec. 31, 2015
Manatuck Hill Partners 784116 $6.74M March 31, 2013
Ironwood Investment Management 738748 $1.43M March 31, 2015
Geode Capital Management 718596 $251508 Dec. 31, 2015
Millennium Management 717510 $1.90M Dec. 31, 2014
Driehaus Capital Management 713498 $6.14M March 31, 2013
PanAgora Asset Management 657055 $229969 Dec. 31, 2015
Deutsche Bank Aktiengesellschaft 652298 $3.42M Dec. 31, 2013